Scottish researchers have found that drugs used to treat Parkinson's disease appear to turn some patients into gambling addicts.
A survey of patients in western Scotland found that about 10 percent of those taking dopamine agents had become problem gamblers, The Scotsman reported. A research team from Southern General Hospital in Glasgow tracked 251 Parkinson's patients who were taking different drug combinations.
Many of the patients who became addicted were already regular bettors before they went on Parkinson's medication. But the increase was often dramatic, like the patient who went from spending 10 pounds a week gambling to 1,500 pounds a week.
Parkinson's patients appear to suffer from low levels of dopamine. Dopamine plays a role in addiction by helping the brain to recognize sources of pleasure.
Robert Brown, a Glasgow psychologist, said that what patients using dopamine are likely to turn to depends on what they have access to.
"There is a tradition of gambling across the whole of Scotland, with more gamblers per head of population than in England and Wales," Brown said. "But people on these drugs could equally turn to alcohol or other ways of finding arousal or escape."
Copyright 2006 by United Press International
Related stories:
Researchers find 'switch' for brain's pleasure pathway
Amid reports that a drug used to treat Parkinson's disease has caused some patients to become addicted to gambling and sex, University of Pittsburgh researchers have published a study that sheds light on what may have gone wrong.
China: 'Out of control' dairy system led to abuse
(AP) -- China's agriculture minister acknowledged Tuesday that the country's milk-gathering system was "out of control" and led to abuses that put contaminated dairy products in stores across Asia, sickening some 54,000 babies and killing four.
A new addiction: Internet junkies
While compulsive gambling is only beginning to be addressed by mental health professionals, they must now face a new affliction: Internet addiction.
Surgical technique halts cell loss, Parkinson's researchers find
Deep brain stimulation, a surgical technique often viewed as a last resort for people with Parkinson's disease, halts the progression of dopamine-cell loss in animal models, according to preliminary research by scientists at the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital.
The first autism disease genes
The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. At the same time an Austrian scientist, Dr. Hans Asperger, described a milder form of the disorder that became known as Asperger Syndrome, characterised by higher cognitive abilities and more normal language function. Today, both disorders are classified in the continuum of 'Pervasive Developmental Disorders' (PDD), more often referred to as Autism Spectrum Disorders (ASD).
Why dopamine freezes parkinson patients and drives drug addicts
Parkinson's disease and drug addiction are polar opposite diseases, but both depend upon dopamine in the brain. Parkinson's patients don't have enough of it; drug addicts get too much of it. Although the importance of dopamine in these disorders has been well known, the way it works has been a mystery.
Blood-related genetic mechanisms found important in Parkinson's disease
What does the genetics of blood cells have to do with brain cells related to Parkinson's disease? From an unusual collaboration of neurologists and a pharmacologist comes the surprising answer: Genetic mechanisms at play in blood cells also control a gene and protein that cause Parkinson's disease.
Protein on 'speed' linked to ADHD
A genetic change in the dopamine transporter – one of the brain's dopamine-handling proteins – makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in
The Journal of Neuroscience.